NEWEarnings
Ali Asif Sells $2.58 Million in Protagonist Therapeutics Stock
Published on 3/27/2026

AI Summary
Ali Asif, a significant stakeholder at Protagonist Therapeutics (PTGX), sold shares worth $2.58 million. This transaction reflects a strategic move within the company, potentially impacting stock performance. As of the latest reporting, precise stock price and volume details were not disclosed, but insider sales can often signal market confidence or concerns. Such developments typically draw attention from investors watching PTGX's performance.
Related News

Earnings
Brava Reports Record Production but Earnings Disappointment in Q4 2025
Mar 28

Earnings
Goldman Sachs Highlights Key Question for S&P 500 in Q2 Earnings
Mar 28

Earnings
EverCommerce Q4 2025 Revenue Beats Expectations Despite Earnings Miss
Mar 28

Earnings
Brava Energia Reports Q4 2025 Earnings Miss; Earnings Drop by X%
Mar 28